T. Rowe Price Investment Management
TNYA icon

T. Rowe Price Investment Management’s Tenaya Therapeutics TNYA Stock Holding History

T. Rowe Price Investment Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,272,192
Closed -$7.47M – 595
2023
Q2 		$7.47M Sell
1,272,192
-292,333
-19% -$1.7M 0.01% 523
2023
Q1 		$4.46M Sell
1,564,525
-220
-0% -$618 ﹤0.01% 534
2022
Q4 		$3.15M Hold
1,564,745
– – ﹤0.01% 531
2022
Q3 		$4.54M Buy
+1,564,745
New +$7.3M ﹤0.01% 528

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

T. Rowe Price Investment Management's TNYA Position: Q3 2023 in Review

T. Rowe Price Investment Management sold out of Tenaya Therapeutics (TNYA) in Q3 2023, closing a stake of 1,272,192 shares — an estimated $7.47M sold.

T. Rowe Price Investment Management first reported a position in TNYA in Q3 2022 and held it in 4 quarters. The position peaked at $7.47M in Q2 2023. 76 funds tracked by Wall St. Rank hold TNYA as of Q3 2023.

  • T. Rowe Price Investment Management reported no remaining Tenaya Therapeutics position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,272,192 Tenaya Therapeutics shares in Q3 2023, an estimated $7.47M.
  • T. Rowe Price Investment Management first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 4 quarters.
  • T. Rowe Price Investment Management's Tenaya Therapeutics position peaked at $7.47M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.